MX9204880A - Composicion farmaceutica para disminuir los niveles de lipidos en la sangre de los mamiferos - Google Patents
Composicion farmaceutica para disminuir los niveles de lipidos en la sangre de los mamiferosInfo
- Publication number
- MX9204880A MX9204880A MX9204880A MX9204880A MX9204880A MX 9204880 A MX9204880 A MX 9204880A MX 9204880 A MX9204880 A MX 9204880A MX 9204880 A MX9204880 A MX 9204880A MX 9204880 A MX9204880 A MX 9204880A
- Authority
- MX
- Mexico
- Prior art keywords
- mammals
- blood
- pharmaceutical composition
- lipid levels
- decrease lipid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US74894491A | 1991-08-23 | 1991-08-23 | |
US92975292A | 1992-08-12 | 1992-08-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
MX9204880A true MX9204880A (es) | 1993-04-01 |
Family
ID=27115023
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX9204880A MX9204880A (es) | 1991-08-23 | 1992-08-21 | Composicion farmaceutica para disminuir los niveles de lipidos en la sangre de los mamiferos |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0599987A4 (es) |
AU (1) | AU2486192A (es) |
CA (1) | CA2115675A1 (es) |
IL (1) | IL102895A0 (es) |
MX (1) | MX9204880A (es) |
NO (1) | NO940580L (es) |
WO (1) | WO1993003734A1 (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1492564A2 (en) * | 2001-10-31 | 2005-01-05 | Université Libre de Bruxelles | Amp-kinase agonists or adenosine pro-drugs as immuno-stimulating agents |
ES2192495B1 (es) | 2002-03-21 | 2005-02-16 | Universidad De Barcelona | Nuevo uso terapeutico del ribosido de 5-aminoimidazol-4-carboxamida (acadesina). |
US8895520B2 (en) | 2011-10-26 | 2014-11-25 | Universite Nice Sophia Antipolis | Method for treating a human patent suffering from Myeloid Neoplasias using 5-aminoimidazole-4-carboxamide |
MY182801A (en) * | 2013-09-26 | 2021-02-05 | Energenesis Biomedical Co Ltd | Compound for activating ampk and uses thereof |
JP7376951B2 (ja) | 2018-08-06 | 2023-11-09 | スカイラーク バイオサイエンス エルエルシー | Amp活性化プロテインキナーゼ活性化化合物およびその使用 |
US11779590B2 (en) | 2020-10-30 | 2023-10-10 | Skylark Bioscience Llc | AMP-activated protein kinase activating compounds and uses thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2026040C3 (de) * | 1970-05-27 | 1975-09-18 | Boehringer Mannheim Gmbh, 6800 Mannheim | Imidazolribosylcyclophosphate |
US3919192A (en) * | 1972-05-22 | 1975-11-11 | Icn Pharmaceuticals | 5-Amino-4-substituted imidazole nucleotides |
US4575498A (en) * | 1983-07-21 | 1986-03-11 | Duke University | Method for restoring depleted purine nucleotide pools |
US4912092A (en) * | 1986-03-27 | 1990-03-27 | The Regents Of The University Of California | Methods for increasing extracellular adenosine and for stabilizing mast cells |
-
1992
- 1992-08-14 WO PCT/US1992/006828 patent/WO1993003734A1/en not_active Application Discontinuation
- 1992-08-14 EP EP92918495A patent/EP0599987A4/en not_active Withdrawn
- 1992-08-14 CA CA002115675A patent/CA2115675A1/en not_active Abandoned
- 1992-08-14 AU AU24861/92A patent/AU2486192A/en not_active Abandoned
- 1992-08-21 MX MX9204880A patent/MX9204880A/es unknown
- 1992-08-21 IL IL102895A patent/IL102895A0/xx unknown
-
1994
- 1994-02-21 NO NO940580A patent/NO940580L/no unknown
Also Published As
Publication number | Publication date |
---|---|
AU2486192A (en) | 1993-03-16 |
IL102895A0 (en) | 1993-01-31 |
EP0599987A4 (en) | 1995-02-01 |
NO940580L (no) | 1994-04-25 |
NO940580D0 (no) | 1994-02-21 |
WO1993003734A1 (en) | 1993-03-04 |
EP0599987A1 (en) | 1994-06-08 |
CA2115675A1 (en) | 1993-03-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX9207222A (es) | Procedimiento para la preparacion de compuestos farmaceuticos que reducen selectivamente el nivel de lipidos de la sangre. | |
MX159428A (es) | Conjunto de bisturi para extraer sangre | |
ES281482Y (es) | Soporte para pisar | |
DK73688A (da) | Flydende enzymformuleringer | |
DE122004000023I2 (de) | Pharmazeutische Zusammensetzung | |
ES541650A0 (es) | Perfeccionamientos en los tobillos biomecanicos para pies artificiales | |
MX9204880A (es) | Composicion farmaceutica para disminuir los niveles de lipidos en la sangre de los mamiferos | |
ES547033A0 (es) | Perfeccionamientos en los dispositivos para la aplicacion demasas cosmeticas | |
MC1878A1 (fr) | Compositions pharmaceutiques | |
ES548133A0 (es) | Perfeccionamientos en los aparatos de cinesiterapia para la resolucion de las anomalias de rodilla | |
MX174530B (es) | Derivados de tripeptidos, procedimientos para la preparacion de derivados de tripeptidos y composiciones que los contienen | |
DK504187D0 (da) | Farmaceutisk praeparat indeholdende mindst en lipidregulator | |
ES544824A0 (es) | Procedimiento para la preparacion de ester tercibutilico de norcarnitina | |
ES550282A0 (es) | Procedimiento para la preparacion de a-l-aspartil-l-fenila- lanina metil ester | |
ATA133288A (de) | Pharmazeutische zusammensetzung | |
IT1222735B (it) | Composizioni farmaceutiche laminate transdermali ad effetto prolungato e procedimento per la loro preparazione | |
IT8847657A0 (it) | Procedimento per la preparazione di derivati stilbenici contenenti gruppi triazinile | |
ITMI911445A1 (it) | Impiego di derivati fosfolipidici per la preparazione di composizioni farmaceutiche aventi attivita' immunosoppressiva | |
MX9206685A (es) | Procedimiento para la preparacion de adipatos de alquilo | |
MX9101959A (es) | Procedimiento para la preparacion de trioxano | |
RO91976A2 (ro) | Compozitie medicamentoasa cu vitamine sub forma de tablete turnate | |
ES550320A0 (es) | Perfeccionamientos en los procedimientos de preparacion de lubricantes para compresores | |
ES2053432T3 (es) | Azapropazona para la prevencion de lesiones post-isquemicas de los tejidos. | |
ES528903A0 (es) | Mejoras introducidas en los mecanismos para movimiento de extremidades en los munecos | |
ES293533Y (es) | Estructura reticular para la formacion de bancadas para maquinaria |